Diseases & Disorders
(G30Z)
IRS Verified
DX Registered
990 on File
LIGA CONTRA EL CANCER INC LEAGUE AGAINST CANCER INC
Financial strength (30%)
78/100
Reliability (20%)
55/100
Effectiveness (25%)
71/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$4.7M
Total Revenue
$4.7M
Total Expenses
$6.7M
Net Assets
17
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
70.7%
Fundraising Efficiency
N/A
Operating Reserve
17.01x
Liability-to-Asset
11.1%
Revenue Diversification
99.4%
Executive Compensation
$169K
Compared with Peers
FY 2025
Compared with 264 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
70.7% | 83.2% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
11.6% | 11.0% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
17.7% | 2.5% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
17.0 mo | 12.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
11.1% | 12.5% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.4% | 87.6% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
80.6% | 7.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
97.5% | 5.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
0.6% | 4.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $4.7M | $4.7M | $6.7M | 70.7% | 17 |
| 2024 | $2.6M | $2.4M | $6.6M | 78.0% | 17 |
| 2023 | $3.3M | $4.2M | $6.3M | 78.1% | 14 |
| 2022 | $4.2M | $4.1M | $7.0M | 77.1% | 18 |
| 2021 | $2.9M | $3.2M | N/A | — | 15 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.